Matisse Capital
- SEC CIK
- 0001668256
- Latest filing
- Aug 12, 2026
WVE holding history
Wave Life Sciences, Inc. in every 13F filed by Matisse Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
WVE overviewAll 13F holders of WVEFull Q2 2026 holdings
- Shares (Q2 2026)
- 45,723
- Value
- $265.7K
- % of portfolio
- 0.1%
- Quarters held
- 19
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 45,723 | $265.7K | 0.1% | −1,000−2.1% | Reduced | Holders |
| Q1 2026 | 46,723 | $338.7K | 0.1% | +4,530+10.7% | Added | Holders |
| Q4 2025 | 42,193 | $717.3K | 0.3% | +29,000+219.8% | Added | Holders |
| Q3 2025 | 13,193 | $96.6K | <0.1% | +2,000+17.9% | Added | Holders |
| Q2 2025 | 11,193 | $72.8K | <0.1% | −1,440−11.4% | Reduced | Holders |
| Q1 2025 | 12,633 | $102.1K | 0.1% | −10−0.1% | Reduced | Holders |
| Q4 2024 | 12,643 | $156.4K | 0.1% | −820−6.1% | Reduced | Holders |
| Q3 2024 | 13,463 | $110.4K | 0.1% | −600−4.3% | Reduced | Holders |
| Q2 2024 | 14,063 | $70.2K | <0.1% | +150+1.1% | Added | Holders |
| Q1 2024 | 13,913 | $85.8K | <0.1% | +1,900+15.8% | Added | Holders |
| Q4 2023 | 12,013 | $60.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 12,013 | $69.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 12,013 | $43.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 12,013 | $52.0K | <0.1% | −200−1.6% | Reduced | Holders |
| Q4 2022 | 12,213 | $85.5K | 0.1% | +12,213 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −13,223−100.0% | Sold out | Holders |
| Q4 2021 | 13,223 | $42.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 13,223 | $65.0K | <0.1% | −1,950−12.9% | Reduced | Holders |
| Q2 2021 | 15,173 | $101.0K | <0.1% | −2,000−11.6% | Reduced | Holders |
| Q1 2021 | 17,173 | $96.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.